London-based LabGenius, which uses AI and "robotic automation" for protein drug discovery, raises $10M Series A led by Lux Capital and Obvious Ventures (Steve O'Hear/TechCrunch)
London-based LabGenius, which uses AI and "robotic automation" for protein drug discovery, raises $10M Series A led by Lux Capital and Obvious Ventures (Steve O'Hear/TechCrunch) https://ift.tt/2oqpywA
London-based LabGenius, which uses AI and “robotic automation” for protein drug discovery, raises $10M Series A led by Lux Capital and Obvious Ventures — LabGenius, a London-based startup applying AI and “robotic automation” to protein drug discovery, has raised $10 million in Series A funding.
0 Response to "London-based LabGenius, which uses AI and "robotic automation" for protein drug discovery, raises $10M Series A led by Lux Capital and Obvious Ventures (Steve O'Hear/TechCrunch)"
Post a Comment
THANK YOU